Medical Device
Cybersecurity &
FDA 510K Clearance
Enabling cybersecurity readiness
for FDA 510(k) clearance
and post-market compliance
Medical Device
Cybersecurity &
FDA 510K Clearance
Medical devices increasingly rely on complex software, connectivity, machine learning and cloud connectivity, introducing cybersecurity risks that must be addressed for FDA clearance. We help manufacturers identify vulnerabilities, conduct penetration testing, implement secure design practices, and generate the cybersecurity documentation required for 510(k) submissions. From threat modeling and SBOM analysis to real-world security testing, our team ensures devices meet FDA cybersecurity expectations. The result: faster regulatory approval, stronger device security, and greater confidence in patient safety.
Features & Benefits
Medical Device Cybersecurity and FDA 510(k) Clearance
Medical Device Cybersecurity Readiness Assessments
FDA 510(k) Cybersecurity Submission Support
Secure-by-Design Architecture and Risk Analysis
Post-market Cybersecurity and Lifecycle Planning
Cybersecurity Training for Engineering and Regulatory Teams
Medical Device Cybersecurity
and FDA 510(k) Clearance
TrustThink provides focused medical device cybersecurity services
that help manufacturers understand FDA cybersecurity expectations,
reduce regulatory risk, and support successful 510(k) submissions.
Medical Device Cybersecurity
Readiness Assessments
Assess the cybersecurity readiness of medical devices and supporting systems against FDA premarket and postmarket cybersecurity expectations.
Assessments focus on device architecture, software and firmware components, interfaces, access controls, update mechanisms, and lifecycle considerations to identify gaps that could impact FDA clearance or long-term compliance.
FDA 510(k) Cybersecurity
Submission Support
Support the development of cybersecurity materials required for FDA 510(k) submissions. This includes cybersecurity risk analysis, secure design descriptions, traceability between risks and mitigations, and postmarket cybersecurity plans.
Work is aligned with current FDA guidance and structured to clearly communicate design decisions and residual risk to FDA reviewers.
Secure-by-Design Architecture
and Risk Analysis
Support product teams in documenting how cybersecurity risks are identified
and addressed through device architecture and design controls.
This includes analyzing interfaces, data flows, software components, and external dependencies to demonstrate that cybersecurity risks to safety and effectiveness have been systematically considered and appropriately controlled.
Post-market Cybersecurity
and Lifecycle Planning
Develop post-market cybersecurity management plans that address
vulnerability monitoring, coordinated disclosure, software updates,
and ongoing risk management throughout the device lifecycle.
Planning aligns with FDA postmarket guidance and supports
sustainable compliance after clearance.
Cybersecurity Training for
Engineering and Regulatory Teams
Develop role-based training that helps:
- Engineering teams understand FDA cybersecurity expectations and apply them during design and development
- Regulatory and quality teams understand how cybersecurity risk management supports safety, effectiveness, and FDA submissions
Experience Meeting FDA Cybersecurity Expectations
Our medical device cybersecurity services are informed by direct experience supporting manufacturers preparing for and responding to FDA cybersecurity review.
This includes:
- Supporting FDA 510(k) submissions with required cybersecurity documentation and supporting analysis
- Developing cybersecurity risk management and postmarket plans aligned with current FDA guidance
- Structuring cybersecurity materials so risk-based decisions and design controls are clear to reviewers
- Aligning device cybersecurity practices with recognized standards referenced by FDA
- Working across engineering, regulatory, and quality teams to reduce rework and review delays
This experience helps ensure cybersecurity materials are consistent, complete, and aligned with how FDA evaluates cybersecurity as part of safety and effectiveness.
A Lifecycle-Oriented Approach to Cybersecurity
TrustThink approaches medical device cybersecurity as a lifecycle activity rather than a one-time submission task.
Medical devices evolve over time through software updates, vulnerability disclosures, and changes in operating environments.
Cybersecurity risk management must therefore remain aligned with:
- Device safety and effectiveness
- FDA premarket and postmarket expectations
- Ongoing software maintenance and update processes
This perspective informs how we assess devices, structure cybersecurity documentation, and support postmarket planning, so manufacturers can maintain compliance without introducing unnecessary process or documentation burden.
Case Study
Training the Next Generation on AI Implementation
Case Study:Training the Next Generation on AI Implementation As artificial intelligence becomes integral to government, industry, and critical infrastructure, the challenge is no longer just adopting AI, it is ensuring there is a workforce capable…
Case Study
Securing Connected Roadways
Case Study:Securing Connected Roadways TrustThink has supported federal, state, and industry stakeholders in strengthening the cybersecurity foundations of connected roadway systems, focusing on trust, interoperability, and practical implementation. As transportation infrastructure becomes increasingly connected, cybersecurity…
Explore Additional Services
AI Capability Maturity Model (CMM)
ITS Cybersecurity
Medical Device Cybersecurity & FDA Compliance
Cryptographic Key Management Systems
Autonomous & Robotic Systems Cybersecurity
Research, Development, & Prototyping
Learn more about TrustThink’s
Medical Device Cybersecurity &
FDA 510K Clearance
Connect with our team to discuss how we can help secure your AI systems against adversarial threats